Clostridium butyricum strains XMC 312 and SWY 13 alleviate dextran sulfate sodium- induced colitis through restoration of intestinal barrier integrity and modulation of gut microbiota

The human gut is a bustling ecosystem, a vast internal landscape where trillions of microscopic life forms coexist with the body's own tissues. In a healthy state, this community of bacteria acts as a diligent workforce, helping to digest food, train the immune system, and, perhaps most importantly, maintain a strong barrier between the gut's contents and the rest of the body. This barrier is not a solid wall but a delicate, living membrane made of cells held together by tight seals and coated in a protective layer of mucus. When this barrier holds firm, the body remains safe from harmful invaders. However, when the barrier is breached or the balance of bacteria is disturbed, the immune system can launch a chaotic and damaging attack on the gut lining itself. This condition, known as ulcerative colitis, causes painful inflammation, bleeding, and a breakdown of the very defenses that keep the body whole. For those suffering from this chronic disease, finding a way to repair the barrier and restore the microbial balance is a critical goal.

Researchers at China Agricultural University recently turned their attention to a specific type of bacteria that naturally produces a substance called butyrate, a nutrient that helps keep gut cells healthy. They focused on two newly discovered strains of this bacterium, named XMC 312 and SWY 13, which were originally found in the droppings of chickens and the stomach fluid of cattle. The scientists wanted to see if these specific strains could act as a remedy for a damaged gut. To test this, they used a standard laboratory model where mice were given a chemical in their drinking water that mimics the symptoms of human ulcerative colitis, causing inflammation and tissue damage. Before exposing the mice to this chemical, the researchers fed them either of the two new bacterial strains to see if the bacteria could prepare the gut to withstand the attack.

The results showed that the mice treated with the bacteria fared significantly better than those that were not. The animals that received the bacterial treatment lost less weight, suffered less from diarrhea and bloody stools, and maintained a longer colon length, which is a key sign of gut health. When the researchers examined the tissue under a microscope, they found that the bacterial treatment had preserved the structure of the gut lining. In the mice that did not receive the bacteria, the protective cells that produce mucus were depleted, and the tight seals between cells were broken, allowing harmful substances to leak through. In contrast, the mice treated with the bacteria, particularly the SWY 13 strain, retained a healthier number of these mucus-producing cells and showed stronger expression of the proteins that hold the gut cells together. This suggests that the bacteria helped reinforce the gut's physical defenses, preventing the internal chaos that leads to severe inflammation.

Beyond simply patching the physical barrier, the bacteria also helped the body manage the chemical stress caused by the inflammation. The treatment boosted the levels of antioxidants in the blood, which are the body's natural tools for neutralizing the damaging molecules that accumulate during disease. It also helped maintain levels of a specific antibody, IgG, which plays a role in immune defense. The study revealed that the bacteria did not just sit passively in the gut; they actively reshaped the microbial community. In the mice with colitis, the bacterial treatment reduced the numbers of harmful bacteria that tend to thrive during inflammation and increased the presence of beneficial groups, such as Bifidobacterium and Lactobacillus. This shift in the microbial population was accompanied by a rise in the production of short-chain fatty acids, the very nutrients that feed the gut lining and keep it healthy.

The researchers observed that while both bacterial strains were effective, they worked in slightly different ways. The SWY 13 strain was particularly good at restoring the mucus layer and increasing a wide range of beneficial bacteria, while the XMC 312 strain showed a strong ability to boost specific protective proteins in the gut wall. Both strains, however, succeeded in calming the immune response and reducing the tissue damage associated with the disease. The study concludes that these two newly isolated strains hold promise as potential probiotics for supporting gut health. While the researchers note that further work is needed to fully understand the safety and long-term effects of these specific strains, their findings provide a clear picture of how certain bacteria can act as guardians, repairing the gut's defenses and restoring the delicate balance of the internal ecosystem when it is under attack.